Susana Clemente
Overview
Explore the profile of Susana Clemente including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dores H, Mendes M, Abreu A, Durazzo A, Rodrigues C, Vilela E, et al.
Rev Port Cardiol
. 2024 Apr;
43(9):525-536.
PMID: 38583860
Cardiopulmonary exercise testing (CPET) provides a noninvasive and integrated assessment of the response of the respiratory, cardiovascular, and musculoskeletal systems to exercise. This information improves the diagnosis, risk stratification, and...
2.
Salvador-Martin S, Rubbini G, Vellosillo P, Zapata-Cobo P, Velasco M, Palomino L, et al.
Biomed Pharmacother
. 2024 Feb;
173:116299.
PMID: 38401525
Background/aims: Changes in gene expression profiles among individuals with inflammatory bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment. The aim of this study was to identify genes...
3.
Zapata-Cobo P, Salvador-Matin S, Velasco M, Palomino L, Clemente S, Segarra O, et al.
Pharmacol Res
. 2023 Sep;
196:106938.
PMID: 37748560
No abstract available.
4.
Zapata-Cobo P, Salvador-Martin S, Velasco M, Palomino L, Clemente S, Segarra O, et al.
Pharmacol Res
. 2023 Jul;
194:106859.
PMID: 37473877
Few genetic polymorphisms predict early response to anti-TNF drugs in inflammatory bowel disease (IBD), and even fewer have been identified in the pediatric population. However, it would be of considerable...
5.
Rolo Silvestre C, Custodio C, Clemente S, Rodrigues S, Furtado S, Maio R
Health Sci Rep
. 2023 Apr;
6(4):e1216.
PMID: 37091361
No abstract available.
6.
Salvador-Martin S, Zapata-Cobo P, Velasco M, Palomino L, Clemente S, Segarra O, et al.
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36675312
The genetic polymorphisms rs2395185 and rs2097432 in HLA genes have been associated with the response to anti-TNF treatment in inflammatory bowel disease (IBD). The aim was to analyze the association...
7.
Hilberg O, Hoffmann-Vold A, Smith V, Bouros D, Kilpelainen M, Guiot J, et al.
ERJ Open Res
. 2022 Jan;
8(1).
PMID: 35083316
The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs), fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated ILD (SSc-ILD), other non-IPF F-ILDs and their...
8.
Salvador-Martin S, Kaczmarczyk B, Alvarez R, Navas-Lopez V, Gallego-Fernandez C, Moreno-Alvarez A, et al.
Pharmaceutics
. 2021 Jan;
13(1).
PMID: 33429950
Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic...
9.
Salvador-Martin S, Bossacoma F, Pujol-Muncunill G, Navas-Lopez V, Gallego-Fernandez C, Viada J, et al.
J Pediatr Gastroenterol Nutr
. 2020 Aug;
71(4):508-515.
PMID: 32773718
Objectives: Inflammatory bowel disease (IBD) is more complex in children and they will have to live with the disease for much longer. For this reason, it is necessary to optimize...
10.
Salvador-Martin S, Pujol-Muncunill G, Bossacoma F, Navas-Lopez V, Gallego-Fernandez C, Segarra O, et al.
Br J Clin Pharmacol
. 2020 Jun;
87(2):447-457.
PMID: 32478906
Aims: Identifying DNA variants associated with trough serum anti-tumour necrosis factor (TNF) levels could predict response to treatment in inflammatory bowel disease (IBD). To date, no specific studies have been...